Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder

Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea

(2015) Yongsoon Park et al.   ANNALS OF NUTRITION AND METABOLISM

Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study

(2015) M H Rapaport et al.   MOLECULAR PSYCHIATRY

Short-term supplementation of acute long-chain omega-3 polyunsaturated fatty acids may alter depression status and decrease symptomology among young adults with depression: A preliminary randomized and placebo controlled trial

(2015) Annie T. Ginty et al.   PSYCHIATRY RESEARCH

Fatty acid metabolism and its longitudinal relationship with the hypothalamic–pituitary–adrenal axis in major depression: Associations with prospective antidepressant response

(2015) Roel J.T. Mocking et al.   PSYCHONEUROENDOCRINOLOGY

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity

(2014) J. Assies et al.   ACTA PSYCHIATRICA SCANDINAVICA

The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial

(2014) Afshin Gharekhani et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Declining efficacy in controlled trials of antidepressants: effects of placebo dropout

(2014) Stein Schalkwijk et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A Double-Blind, Randomized Controlled Clinical Trial Comparing Eicosapentaenoic Acid Versus Docosahexaenoic Acid for Depression

(2014) David Mischoulon et al.   JOURNAL OF CLINICAL PSYCHIATRY

Polyunsaturated fatty acids and their metabolites in brain function and disease

(2014) Richard P. Bazinet et al.   NATURE REVIEWS NEUROSCIENCE

Role of Omega-3 Fatty Acids in the Treatment of Depressive Disorders: A Comprehensive Meta-Analysis of Randomized Clinical Trials

(2014) Giuseppe Grosso et al.   PLoS One

What's in Placebos: Who Knows? Analysis of Randomized, Controlled Trials

(2013) Beatrice A. Golomb et al.   ANNALS OF INTERNAL MEDICINE

EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials

(2013) Julian G Martins   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Effect of Omega-3 Fatty Acids Supplementation on Depressive Symptoms and on Health-Related Quality of Life in the Treatment of Elderly Women with Depression: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

(2013) Mariangela Rondanelli et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Long-Chain Polyunsaturated Fatty Acids Promote Paclitaxel Cytotoxicity via Inhibition of the MDR1 Gene in the Human Colon Cancer Caco-2 Cell Line

(2013) Cheng-Yi Kuan et al.   JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) Polymorphism in Recurrent Depression: Associations with Fatty Acid Concentrations and Waist Circumference

(2013) Roel J. T. Mocking et al.   PLoS One

Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: A randomized, double-blind, placebo-controlled trial

(2012) Hassan Mozaffari-Khosravi et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices

(2012) Roel J. T. Mocking et al.   LIPIDS

Distinguishing Health Benefits of Eicosapentaenoic and Docosahexaenoic Acids

(2012) Fraser Russell et al.   Marine Drugs

Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation and severity of depression

(2012) P-Y Lin et al.   MOLECULAR PSYCHIATRY

Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis

(2012) J G Martins et al.   MOLECULAR PSYCHIATRY

Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters

(2012) Angela Maria Rizzo et al.   Nutrition Journal

Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial

(2012) Roel J. T. Mocking et al.   PLoS One

Bimodal Distribution of Fatty Acids in Recurrent Major Depressive Disorder

(2011) Roel J.T. Mocking et al.   BIOLOGICAL PSYCHIATRY

Dietary n-3 Polyunsaturated Fatty Acids and the Paradox of Their Health Benefits and Potential Harmful Effects

(2011) Simona Serini et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression

(2011) M. Elizabeth Sublette et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder

(2011) Lev Gertsik et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: Effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life

(2011) Mariangela Rondanelli et al.   Journal of Nutrition Health & Aging

Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis

(2011) M H Bloch et al.   MOLECULAR PSYCHIATRY

Updated systematic review and meta-analysis of the effects of n−3 long-chain polyunsaturated fatty acids on depressed mood

(2010) Katherine M Appleton et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression

(2010) Pao-Yen Lin et al.   BIOLOGICAL PSYCHIATRY

Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: A randomized, double-blind placebo-controlled study

(2010) M. Bot et al.   JOURNAL OF AFFECTIVE DISORDERS

The Efficacy of Omega-3 Supplementation for Major Depression

(2010) François Lespérance et al.   JOURNAL OF CLINICAL PSYCHIATRY

Omega-3 Augmentation of Sertraline in Treatment of Depression in Patients With Coronary Heart Disease

(2009) Robert M. Carney et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A Double-Blind, Randomized Controlled Trial of Ethyl-Eicosapentaenoate for Major Depressive Disorder

(2009) David Mischoulon et al.   JOURNAL OF CLINICAL PSYCHIATRY

Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial

(2008) Michel Lucas et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Comparison of Therapeutic Effects of Omega-3 Fatty Acid Eicosapentaenoic Acid and Fluoxetine, Separately and in Combination, in Major Depressive Disorder

(2008) Shima Jazayeri et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Depression in Parkinson's disease: A double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation

(2008) Ticyana Moralez da Silva et al.   JOURNAL OF AFFECTIVE DISORDERS